Another French Study Looks Into The Use of Nicotine Against COVID-19

An earlier study conducted in a large French university hospital, between March and April, aimed to determine the possible correlation of daily smoking, with the susceptibility of contracting the SARS-CoV-2 infection. The researchers had estimated the rates of daily current smokers among COVID-19-infected patients and compared them to the rates of daily current smokers within the general French population, after controlling the data for sex and age.

The compiled data had indicated that the daily smokers’ rate amongst COVID-19 patients was at 5.3%, whilst within the general French population, the rate of daily smokers rate was of 25.4%. These findings had led the researchers to conclude that daily smokers have a significantly lower probability of developing symptomatic or a severe SARS-CoV-2 infection, when compared to the general population.

Less smokers than non-smokers are found among hospitalized COVID-19 patients

The daily smokers rate amongst COVID-19 patients was at 5.3%, whilst amongst the general population, the daily smokers rate was at 25.4%.In line with this, back in March, renowned anti-smoking researcher Dr. Konstantinos Farsalinos and two colleagues, analyzed data coming out of China, where it was widely speculated that the higher hospitalization and death rates among Chinese men was due to gender differences in smoking rates. However, Farsalinos found that there were significantly less smokers among hospitalized COVID-19 patients.

Similarly, another review of the Chinese data published in the European Journal of Internal Medicine concluded that “active smoking does not apparently seem to be significantly associated with enhanced risk of progressing towards severe disease in COVID-19.”

Subsequently, similar patterns started emerging from around the world. Data from the Centers for Disease Control and Prevention (CDC) have shown that smokers represented just 1.3% of COVID-19 cases analyzed, while America’s adult smoking rate is at 13.7%.